25 XP   0   0   10

Sun Pharmaceutical Industries Limited
Buy, Hold or Sell?

Let's analyse Sun Pharmaceutical Industries Limited together

PenkeI guess you are interested in Sun Pharmaceutical Industries Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sun Pharmaceutical Industries Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sun Pharmaceutical Industries Limited

I send you an email if I find something interesting about Sun Pharmaceutical Industries Limited.

Quick analysis of Sun Pharmaceutical Industries Limited (30 sec.)










What can you expect buying and holding a share of Sun Pharmaceutical Industries Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.50
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR247.22
Expected worth in 1 year
INR384.74
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR179.52
Return On Investment
11.8%

For what price can you sell your share?

Current Price per Share
INR1,516.40
Expected price per share
INR1,227 - INR1,639
How sure are you?
50%

1. Valuation of Sun Pharmaceutical Industries Limited (5 min.)




Live pricePrice per Share (EOD)

INR1,516.40

Intrinsic Value Per Share

INR-5.34 - INR216.73

Total Value Per Share

INR241.88 - INR463.95

2. Growth of Sun Pharmaceutical Industries Limited (5 min.)




Is Sun Pharmaceutical Industries Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$7.1b$6.1b$989.9m13.9%

How much money is Sun Pharmaceutical Industries Limited making?

Current yearPrevious yearGrowGrow %
Making money$1b$392.7m$624.1m61.4%
Net Profit Margin19.6%8.5%--

How much money comes from the company's main activities?

3. Financial Health of Sun Pharmaceutical Industries Limited (5 min.)




What can you expect buying and holding a share of Sun Pharmaceutical Industries Limited? (5 min.)

Welcome investor! Sun Pharmaceutical Industries Limited's management wants to use your money to grow the business. In return you get a share of Sun Pharmaceutical Industries Limited.

What can you expect buying and holding a share of Sun Pharmaceutical Industries Limited?

First you should know what it really means to hold a share of Sun Pharmaceutical Industries Limited. And how you can make/lose money.

Speculation

The Price per Share of Sun Pharmaceutical Industries Limited is INR1,516. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sun Pharmaceutical Industries Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sun Pharmaceutical Industries Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR247.22. Based on the TTM, the Book Value Change Per Share is INR34.38 per quarter. Based on the YOY, the Book Value Change Per Share is INR6.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR10.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sun Pharmaceutical Industries Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.420.0%0.420.0%0.160.0%0.210.0%0.210.0%
Usd Book Value Change Per Share0.410.0%0.410.0%0.080.0%0.170.0%0.210.0%
Usd Dividend Per Share0.130.0%0.130.0%0.110.0%0.080.0%0.050.0%
Usd Total Gains Per Share0.540.0%0.540.0%0.190.0%0.250.0%0.270.0%
Usd Price Per Share11.80-11.80-10.98-7.98-8.31-
Price to Earnings Ratio27.84-27.84-67.06-41.97-43.19-
Price-to-Total Gains Ratio21.91-21.91-58.60-41.15-37.35-
Price to Book Ratio3.98-3.98-4.30-3.09-4.33-
Price-to-Total Gains Ratio21.91-21.91-58.60-41.15-37.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.1968
Number of shares54
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.08
Usd Book Value Change Per Share0.410.17
Usd Total Gains Per Share0.540.25
Gains per Quarter (54 shares)29.0813.73
Gains per Year (54 shares)116.3354.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12789106173745
2541782223575100
38226733852112155
410935645470150210
513644657087187265
6163535686105225320
7190624802122262375
8218713918140300430
92458021034157337485
102728911150175374540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%

Fundamentals of Sun Pharmaceutical Industries Limited

About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-14 09:01:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Sun Pharmaceutical Industries Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sun Pharmaceutical Industries Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 19.6% means that ₹0.20 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 19.6%. The company is making a huge profit. +2
  • The TTM is 19.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.6%TTM19.6%0.0%
TTM19.6%YOY8.5%+11.1%
TTM19.6%5Y11.6%+8.0%
5Y11.6%10Y14.3%-2.7%
1.1.2. Return on Assets

Shows how efficient Sun Pharmaceutical Industries Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.5% Return on Assets means that Sun Pharmaceutical Industries Limited generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 10.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.5%TTM10.5%0.0%
TTM10.5%YOY4.7%+5.8%
TTM10.5%5Y5.8%+4.7%
5Y5.8%10Y7.2%-1.4%
1.1.3. Return on Equity

Shows how efficient Sun Pharmaceutical Industries Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 15.1% Return on Equity means Sun Pharmaceutical Industries Limited generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 15.1%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 15.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.1%TTM15.1%0.0%
TTM15.1%YOY6.8%+8.3%
TTM15.1%5Y8.6%+6.5%
5Y8.6%10Y11.7%-3.1%

1.2. Operating Efficiency of Sun Pharmaceutical Industries Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sun Pharmaceutical Industries Limited is operating .

  • Measures how much profit Sun Pharmaceutical Industries Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 22.5% means the company generated ₹0.23  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 22.5%. The company is operating efficient. +1
  • The TTM is 22.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ22.5%TTM22.5%0.0%
TTM22.5%YOY24.6%-2.1%
TTM22.5%5Y20.8%+1.7%
5Y20.8%10Y25.0%-4.2%
1.2.2. Operating Ratio

Measures how efficient Sun Pharmaceutical Industries Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are ₹0.79 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 0.786. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.786. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.786TTM0.7860.000
TTM0.786YOY0.779+0.007
TTM0.7865Y0.811-0.025
5Y0.81110Y0.767+0.044

1.3. Liquidity of Sun Pharmaceutical Industries Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sun Pharmaceutical Industries Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.00 means the company has ₹2.00 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 2.002. The company is able to pay all its short-term debts. +1
  • The TTM is 2.002. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.002TTM2.0020.000
TTM2.002YOY2.036-0.033
TTM2.0025Y1.946+0.056
5Y1.94610Y2.040-0.093
1.3.2. Quick Ratio

Measures if Sun Pharmaceutical Industries Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.94 means the company can pay off ₹1.94 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 1.944. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.944. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.944TTM1.9440.000
TTM1.944YOY1.983-0.039
TTM1.9445Y1.774+0.170
5Y1.77410Y1.929-0.156

1.4. Solvency of Sun Pharmaceutical Industries Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sun Pharmaceutical Industries Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sun Pharmaceutical Industries Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Sun Pharmaceutical Industries Limited assets are financed with 26.5% credit (debt) and the remaining percentage (100% - 26.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 0.265. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.265. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.265TTM0.2650.000
TTM0.265YOY0.268-0.003
TTM0.2655Y0.278-0.013
5Y0.27810Y0.315-0.037
1.4.2. Debt to Equity Ratio

Measures if Sun Pharmaceutical Industries Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 38.3% means that company has ₹0.38 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sun Pharmaceutical Industries Limited:

  • The MRQ is 0.383. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.383. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.383TTM0.3830.000
TTM0.383YOY0.390-0.008
TTM0.3835Y0.414-0.031
5Y0.41410Y0.511-0.097

2. Market Valuation of Sun Pharmaceutical Industries Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Sun Pharmaceutical Industries Limited generates.

  • Above 15 is considered overpriced but always compare Sun Pharmaceutical Industries Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 27.84 means the investor is paying ₹27.84 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sun Pharmaceutical Industries Limited:

  • The EOD is 42.938. Based on the earnings, the company is overpriced. -1
  • The MRQ is 27.837. Based on the earnings, the company is overpriced. -1
  • The TTM is 27.837. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD42.938MRQ27.837+15.101
MRQ27.837TTM27.8370.000
TTM27.837YOY67.063-39.226
TTM27.8375Y41.970-14.133
5Y41.97010Y43.188-1.218
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sun Pharmaceutical Industries Limited:

  • The EOD is 126.606. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 82.080. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 82.080. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD126.606MRQ82.080+44.526
MRQ82.080TTM82.0800.000
TTM82.080YOY29.305+52.776
TTM82.0805Y8.778+73.302
5Y8.77810Y34.052-25.274
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sun Pharmaceutical Industries Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.98 means the investor is paying ₹3.98 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Sun Pharmaceutical Industries Limited:

  • The EOD is 6.134. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.977. Based on the equity, the company is fair priced.
  • The TTM is 3.977. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.134MRQ3.977+2.157
MRQ3.977TTM3.9770.000
TTM3.977YOY4.298-0.321
TTM3.9775Y3.093+0.884
5Y3.09310Y4.334-1.241
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sun Pharmaceutical Industries Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--34.38234.3820%6.611+420%14.447+138%17.793+93%
Book Value Per Share--247.216247.2160%212.834+16%211.483+17%175.165+41%
Current Ratio--2.0022.0020%2.036-2%1.946+3%2.040-2%
Debt To Asset Ratio--0.2650.2650%0.268-1%0.278-5%0.315-16%
Debt To Equity Ratio--0.3830.3830%0.390-2%0.414-8%0.511-25%
Dividend Per Share--10.49810.4980%8.998+17%6.749+56%4.452+136%
Eps--35.31635.3160%13.640+159%17.572+101%17.641+100%
Free Cash Flow Per Share--11.97711.9770%31.215-62%16.138-26%14.198-16%
Free Cash Flow To Equity Per Share--21.88021.8800%9.569+129%1.764+1140%4.379+400%
Gross Profit Margin--1.0001.0000%-0.003+100%0.307+226%0.381+162%
Intrinsic Value_10Y_max--216.732--------
Intrinsic Value_10Y_min---5.341--------
Intrinsic Value_1Y_max--21.473--------
Intrinsic Value_1Y_min--10.591--------
Intrinsic Value_3Y_max--64.704--------
Intrinsic Value_3Y_min--22.373--------
Intrinsic Value_5Y_max--108.162--------
Intrinsic Value_5Y_min--23.711--------
Market Cap3638344084787.200+35%2358786209007.0002358786209007.0000%2194791663807.500+7%1596421064275.190+48%1664076486601.605+42%
Net Profit Margin--0.1960.1960%0.085+130%0.116+69%0.143+37%
Operating Margin--0.2250.2250%0.246-8%0.208+8%0.250-10%
Operating Ratio--0.7860.7860%0.779+1%0.811-3%0.767+3%
Pb Ratio6.134+35%3.9773.9770%4.298-7%3.093+29%4.334-8%
Pe Ratio42.938+35%27.83727.8370%67.063-58%41.970-34%43.188-36%
Price Per Share1516.400+35%983.100983.1000%914.750+7%665.360+48%692.870+42%
Price To Free Cash Flow Ratio126.606+35%82.08082.0800%29.305+180%8.778+835%34.052+141%
Price To Total Gains Ratio33.788+35%21.90521.9050%58.603-63%41.148-47%37.345-41%
Quick Ratio--1.9441.9440%1.983-2%1.774+10%1.929+1%
Return On Assets--0.1050.1050%0.047+124%0.058+80%0.072+45%
Return On Equity--0.1510.1510%0.068+122%0.086+76%0.117+29%
Total Gains Per Share--44.88044.8800%15.609+188%21.196+112%22.244+102%
Usd Book Value--7117856400.0007117856400.0000%6127933200.000+16%6089008800.000+17%5046594000.000+41%
Usd Book Value Change Per Share--0.4130.4130%0.079+420%0.173+138%0.214+93%
Usd Book Value Per Share--2.9672.9670%2.554+16%2.538+17%2.102+41%
Usd Dividend Per Share--0.1260.1260%0.108+17%0.081+56%0.053+136%
Usd Eps--0.4240.4240%0.164+159%0.211+101%0.212+100%
Usd Free Cash Flow--344850000.000344850000.0000%898740000.000-62%464637360.000-26%409101120.000-16%
Usd Free Cash Flow Per Share--0.1440.1440%0.375-62%0.194-26%0.170-16%
Usd Free Cash Flow To Equity Per Share--0.2630.2630%0.115+129%0.021+1140%0.053+400%
Usd Market Cap43660129017.446+35%28305434508.08428305434508.0840%26337499965.690+7%19157052771.302+48%19968917839.219+42%
Usd Price Per Share18.197+35%11.79711.7970%10.977+7%7.984+48%8.314+42%
Usd Profit--1016829600.0001016829600.0000%392727600.000+159%505931520.000+101%511237920.000+99%
Usd Revenue--5193464400.0005193464400.0000%4611170400.000+13%4220542080.000+23%3635260200.000+43%
Usd Total Gains Per Share--0.5390.5390%0.187+188%0.254+112%0.267+102%
 EOD+4 -4MRQTTM+0 -0YOY+26 -105Y+29 -710Y+27 -9

3.2. Fundamental Score

Let's check the fundamental score of Sun Pharmaceutical Industries Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1542.938
Price to Book Ratio (EOD)Between0-16.134
Net Profit Margin (MRQ)Greater than00.196
Operating Margin (MRQ)Greater than00.225
Quick Ratio (MRQ)Greater than11.944
Current Ratio (MRQ)Greater than12.002
Debt to Asset Ratio (MRQ)Less than10.265
Debt to Equity Ratio (MRQ)Less than10.383
Return on Equity (MRQ)Greater than0.150.151
Return on Assets (MRQ)Greater than0.050.105
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Sun Pharmaceutical Industries Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,545.550
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets807,435,900
Total Liabilities214,281,200
Total Stockholder Equity559,953,800
 As reported
Total Liabilities 214,281,200
Total Stockholder Equity+ 559,953,800
Total Assets = 807,435,900

Assets

Total Assets807,435,900
Total Current Assets398,619,400
Long-term Assets408,602,500
Total Current Assets
Cash And Cash Equivalents 46,237,300
Short-term Investments 112,836,800
Net Receivables 115,012,300
Inventory 105,130,500
Other Current Assets 19,402,500
Total Current Assets  (as reported)398,619,400
Total Current Assets  (calculated)398,619,400
+/-0
Long-term Assets
Property Plant Equipment 113,537,300
Goodwill 87,127,100
Intangible Assets 93,268,400
Long-term Assets Other 28,452,500
Long-term Assets  (as reported)408,602,500
Long-term Assets  (calculated)322,385,300
+/- 86,217,200

Liabilities & Shareholders' Equity

Total Current Liabilities199,063,800
Long-term Liabilities15,217,400
Total Stockholder Equity559,953,800
Total Current Liabilities
Short-term Debt 63,259,600
Short Long Term Debt 61,978,800
Accounts payable 56,815,200
Other Current Liabilities 6,427,200
Total Current Liabilities  (as reported)199,063,800
Total Current Liabilities  (calculated)188,480,800
+/- 10,583,000
Long-term Liabilities
Long term Debt Total 5,599,100
Capital Lease Obligations 1,318,700
Long-term Liabilities Other 5,828,200
Long-term Liabilities  (as reported)15,217,400
Long-term Liabilities  (calculated)12,746,000
+/- 2,471,400
Total Stockholder Equity
Retained Earnings 472,009,000
Accumulated Other Comprehensive Income 109,534,100
Capital Surplus 11,874,100
Total Stockholder Equity (as reported)559,953,800
Total Stockholder Equity (calculated)593,417,200
+/- 33,463,400
Other
Capital Stock2,399,300
Cash And Equivalents13,871,700
Cash and Short Term Investments 159,074,100
Common Stock Shares Outstanding 2,399,335
Current Deferred Revenue72,561,800
Liabilities and Stockholders Equity 807,435,900
Net Debt 22,659,300
Net Invested Capital 627,531,700
Net Working Capital 199,555,600
Property Plant and Equipment Gross 113,537,300
Short Long Term Debt Total 68,896,600



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-31
> Total Assets 
15,229,400
33,181,300
39,545,700
43,250,400
59,701,200
82,634,500
90,720,800
123,142,300
162,603,900
208,812,100
293,708,200
490,279,000
542,195,500
614,102,400
643,028,000
646,938,100
682,524,600
676,667,300
697,998,700
807,435,900
807,435,900697,998,700676,667,300682,524,600646,938,100643,028,000614,102,400542,195,500490,279,000293,708,200208,812,100162,603,900123,142,30090,720,80082,634,50059,701,20043,250,40039,545,70033,181,30015,229,400
   > Total Current Assets 
6,923,800
18,946,300
26,520,400
29,888,500
40,367,500
42,682,900
37,121,100
60,172,100
101,407,600
118,015,700
186,864,600
291,219,400
308,645,700
329,536,500
316,359,000
310,691,900
316,541,600
304,420,800
350,149,800
398,619,400
398,619,400350,149,800304,420,800316,541,600310,691,900316,359,000329,536,500308,645,700291,219,400186,864,600118,015,700101,407,60060,172,10037,121,10042,682,90040,367,50029,888,50026,520,40018,946,3006,923,800
       Cash And Cash Equivalents 
945,500
11,808,900
15,322,800
13,802,100
13,382,000
16,690,300
6,072,800
21,936,400
17,526,700
20,691,100
43,587,000
72,855,600
81,196,000
86,628,000
79,253,700
70,623,000
56,766,100
62,730,300
45,082,500
46,237,300
46,237,30045,082,50062,730,30056,766,10070,623,00079,253,70086,628,00081,196,00072,855,60043,587,00020,691,10017,526,70021,936,4006,072,80016,690,30013,382,00013,802,10015,322,80011,808,900945,500
       Short-term Investments 
0
0
0
0
0
0
0
0
32,384,000
32,948,200
52,299,100
58,299,100
65,849,300
66,882,700
60,516,500
41,165,800
52,631,900
32,901,500
81,465,400
112,836,800
112,836,80081,465,40032,901,50052,631,90041,165,80060,516,50066,882,70065,849,30058,299,10052,299,10032,948,20032,384,00000000000
       Net Receivables 
2,250,000
2,510,600
3,608,900
6,788,800
14,176,700
8,810,900
11,747,700
22,996,700
30,282,600
38,598,500
35,672,300
77,782,500
96,939,100
107,529,500
107,470,400
119,494,900
127,419,400
118,310,600
133,092,900
115,012,300
115,012,300133,092,900118,310,600127,419,400119,494,900107,470,400107,529,50096,939,10077,782,50035,672,30038,598,50030,282,60022,996,70011,747,7008,810,90014,176,7006,788,8003,608,9002,510,6002,250,000
       Inventory 
2,542,200
3,172,900
5,117,400
6,644,700
7,727,700
9,757,000
10,738,500
14,793,900
20,869,800
25,777,600
31,230,100
56,679,900
64,236,300
68,328,100
68,806,900
78,859,800
78,749,900
89,970,200
89,968,100
105,130,500
105,130,50089,968,10089,970,20078,749,90078,859,80068,806,90068,328,10064,236,30056,679,90031,230,10025,777,60020,869,80014,793,90010,738,5009,757,0007,727,7006,644,7005,117,4003,172,9002,542,200
       Other Current Assets 
1,186,100
1,453,900
2,471,300
2,652,900
5,081,100
7,424,700
8,562,100
445,100
344,500
300
24,076,100
25,602,300
425,000
168,200
311,500
548,400
974,300
508,200
540,900
19,402,500
19,402,500540,900508,200974,300548,400311,500168,200425,00025,602,30024,076,100300344,500445,1008,562,1007,424,7005,081,1002,652,9002,471,3001,453,9001,186,100
   > Long-term Assets 
8,305,600
14,235,000
13,025,300
13,361,900
19,333,700
39,951,600
53,599,700
62,970,200
61,196,300
90,796,400
106,843,600
199,059,600
233,549,800
284,565,900
326,669,000
336,246,200
365,983,000
372,246,500
347,848,900
408,602,500
408,602,500347,848,900372,246,500365,983,000336,246,200326,669,000284,565,900233,549,800199,059,600106,843,60090,796,40061,196,30062,970,20053,599,70039,951,60019,333,70013,361,90013,025,30014,235,0008,305,600
       Property Plant Equipment 
4,928,200
6,212,600
8,977,200
10,121,900
11,039,600
16,196,400
15,089,900
25,059,800
29,581,600
37,230,400
43,397,200
85,069,500
87,593,800
100,600,500
105,935,000
109,382,100
112,263,400
111,715,100
111,688,900
113,537,300
113,537,300111,688,900111,715,100112,263,400109,382,100105,935,000100,600,50087,593,80085,069,50043,397,20037,230,40029,581,60025,059,80015,089,90016,196,40011,039,60010,121,9008,977,2006,212,6004,928,200
       Goodwill 
0
0
0
0
0
0
4,060,300
7,719,700
10,218,100
11,329,500
29,123,200
50,611,600
55,938,600
55,362,200
56,067,100
59,557,700
64,814,600
62,876,400
65,494,500
87,127,100
87,127,10065,494,50062,876,40064,814,60059,557,70056,067,10055,362,20055,938,60050,611,60029,123,20011,329,50010,218,1007,719,7004,060,300000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
7,875,600
5,988,700
19,137,600
14,903,800
30,831,900
39,518,100
0
0
0
0
000039,518,10030,831,90014,903,80019,137,6005,988,7007,875,6000000000000
       Intangible Assets 
1,612,100
1,537,600
506,900
697,100
1,729,300
3,253,400
1,686,200
2,880,500
3,160,300
13,540,900
4,067,800
11,529,700
31,884,700
48,802,800
51,176,000
63,537,100
63,594,500
56,606,600
60,282,000
93,268,400
93,268,40060,282,00056,606,60063,594,50063,537,10051,176,00048,802,80031,884,70011,529,7004,067,80013,540,9003,160,3002,880,5001,686,2003,253,4001,729,300697,100506,9001,537,6001,612,100
       Long-term Assets Other 
1,765,300
6,484,800
3,541,200
2,542,900
6,564,800
18,594,900
30,663,800
22,309,600
34,342,800
38,956,400
57,122,500
74,618,000
81,947,100
112,144,900
121,547,100
79,868,300
41,100,100
40,660,100
31,824,200
28,452,500
28,452,50031,824,20040,660,10041,100,10079,868,300121,547,100112,144,90081,947,10074,618,00057,122,50038,956,40034,342,80022,309,60030,663,80018,594,9006,564,8002,542,9003,541,2006,484,8001,765,300
> Total Liabilities 
6,987,300
21,712,800
23,312,500
15,084,900
7,900,900
10,214,900
10,499,800
19,837,600
29,325,900
42,564,000
89,246,900
205,386,200
187,294,100
209,797,100
223,180,800
199,712,100
191,277,700
181,869,000
187,337,600
214,281,200
214,281,200187,337,600181,869,000191,277,700199,712,100223,180,800209,797,100187,294,100205,386,20089,246,90042,564,00029,325,90019,837,60010,499,80010,214,9007,900,90015,084,90023,312,50021,712,8006,987,300
   > Total Current Liabilities 
2,116,300
2,586,500
3,514,500
3,045,500
6,373,000
7,198,100
7,579,200
14,233,500
24,658,800
31,397,900
59,895,900
163,530,000
132,476,600
178,870,200
198,643,200
173,396,200
157,064,300
161,456,300
172,005,500
199,063,800
199,063,800172,005,500161,456,300157,064,300173,396,200198,643,200178,870,200132,476,600163,530,00059,895,90031,397,90024,658,80014,233,5007,579,2007,198,1006,373,0003,045,5003,514,5002,586,5002,116,300
       Short-term Debt 
17,500
24,200
33,100
22,000
17,600
0
0
0
1,690,500
1,468,500
25,150,500
76,388,900
54,243,700
83,956,900
86,131,800
89,917,500
62,859,600
29,704,500
8,085,900
63,259,600
63,259,6008,085,90029,704,50062,859,60089,917,50086,131,80083,956,90054,243,70076,388,90025,150,5001,468,5001,690,50000017,60022,00033,10024,20017,500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
25,637,200
13,975,800
1,770,700
83,917,400
85,903,300
89,568,500
61,932,400
24,449,000
7,007,700
61,978,800
61,978,8007,007,70024,449,00061,932,40089,568,50085,903,30083,917,4001,770,70013,975,80025,637,2000000000000
       Accounts payable 
924,500
1,063,200
1,110,100
967,600
2,393,400
2,543,400
19,100
37,700
8,401,100
13,565,300
13,282,600
31,538,300
34,895,800
43,953,900
47,662,000
41,478,700
40,937,300
39,736,600
44,793,400
56,815,200
56,815,20044,793,40039,736,60040,937,30041,478,70047,662,00043,953,90034,895,80031,538,30013,282,60013,565,3008,401,10037,70019,1002,543,4002,393,400967,6001,110,1001,063,200924,500
       Other Current Liabilities 
412,800
620,800
1,073,600
1,810,700
1,215,400
4,654,700
7,560,100
14,195,800
3,570,600
774,500
1,013,100
11,562,700
5,845,000
3,401,300
5,032,600
4,443,800
4,218,900
5,137,000
5,103,800
6,427,200
6,427,2005,103,8005,137,0004,218,9004,443,8005,032,6003,401,3005,845,00011,562,7001,013,100774,5003,570,60014,195,8007,560,1004,654,7001,215,4001,810,7001,073,600620,800412,800
   > Long-term Liabilities 
4,871,000
19,126,300
19,798,000
12,039,400
1,527,900
3,016,800
2,920,600
5,604,100
4,667,100
11,166,100
29,351,000
41,856,200
54,817,500
30,926,900
24,537,600
26,315,900
34,213,400
20,412,700
15,332,100
15,217,400
15,217,40015,332,10020,412,70034,213,40026,315,90024,537,60030,926,90054,817,50041,856,20029,351,00011,166,1004,667,1005,604,1002,920,6003,016,8001,527,90012,039,40019,798,00019,126,3004,871,000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
31,103,000
14,360,800
17,720,900
15,226,100
20,289,200
8,981,300
4,817,100
5,599,100
5,599,1004,817,1008,981,30020,289,20015,226,10017,720,90014,360,80031,103,000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
28,864,300
27,939,900
22,082,800
16,566,100
6,816,700
11,089,800
13,924,200
11,431,400
10,515,000
0
010,515,00011,431,40013,924,20011,089,8006,816,70016,566,10022,082,80027,939,90028,864,3000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
1,100
0
0
0
0
0
0
0
0
0
0000000001,1000000000000
> Total Stockholder Equity
8,158,800
11,307,400
15,901,600
27,727,900
49,914,600
70,449,200
78,289,100
94,833,200
121,663,500
149,897,300
185,249,500
256,380,900
314,048,900
366,396,700
381,005,600
414,090,600
452,644,500
464,627,800
480,112,200
559,953,800
559,953,800480,112,200464,627,800452,644,500414,090,600381,005,600366,396,700314,048,900256,380,900185,249,500149,897,300121,663,50094,833,20078,289,10070,449,20049,914,60027,727,90015,901,60011,307,4008,158,800
   Common Stock
618,300
941,600
942,900
980,700
1,035,600
1,035,600
1,035,600
1,035,600
1,035,600
1,035,600
2,071,200
2,071,200
2,406,600
2,399,300
2,399,300
2,399,300
2,399,300
2,399,300
2,399,300
2,399,300
2,399,3002,399,3002,399,3002,399,3002,399,3002,399,3002,399,3002,406,6002,071,2002,071,2001,035,6001,035,6001,035,6001,035,6001,035,6001,035,600980,700942,900941,600618,300
   Retained Earnings 
2,870,700
4,464,400
6,892,700
11,251,300
20,559,400
31,021,800
38,211,700
47,159,800
60,533,300
89,979,500
117,759,500
169,714,700
212,746,200
306,456,900
317,641,500
333,301,900
353,200,500
365,980,900
376,456,500
472,009,000
472,009,000376,456,500365,980,900353,200,500333,301,900317,641,500306,456,900212,746,200169,714,700117,759,50089,979,50060,533,30047,159,80038,211,70031,021,80020,559,40011,251,3006,892,7004,464,4002,870,700
   Accumulated Other Comprehensive Income 
-1,713,300
-2,087,100
-3,779,000
-4,737,500
-5,606,800
-6,850,700
-7,238,500
-16,817,600
-20,407,200
-24,421,400
-28,903,900
-60,617,200
-73,865,500
-49,041,300
-57,174,200
-67,280,500
-79,167,900
84,329,700
89,338,500
109,534,100
109,534,10089,338,50084,329,700-79,167,900-67,280,500-57,174,200-49,041,300-73,865,500-60,617,200-28,903,900-24,421,400-20,407,200-16,817,600-7,238,500-6,850,700-5,606,800-4,737,500-3,779,000-2,087,100-1,713,300
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
18,591,900
11,894,600
11,929,100
11,932,900
11,874,100
11,874,100
11,874,100
11,874,100
11,874,10011,874,10011,874,10011,874,10011,932,90011,929,10011,894,60018,591,900000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
6,383,100
7,988,500
11,845,000
20,233,400
33,926,400
45,242,500
46,280,300
63,455,400
80,501,800
83,303,600
94,322,700
145,212,200
172,761,600
106,581,800
118,139,000
145,669,900
-391,451,300
11,917,900
11,917,900
-474,408,300
-474,408,30011,917,90011,917,900-391,451,300145,669,900118,139,000106,581,800172,761,600145,212,20094,322,70083,303,60080,501,80063,455,40046,280,30045,242,50033,926,40020,233,40011,845,0007,988,5006,383,100



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue432,788,700
Cost of Revenue-106,621,600
Gross Profit326,167,100326,167,100
 
Operating Income (+$)
Gross Profit326,167,100
Operating Expense-233,732,500
Operating Income93,047,50092,434,600
 
Operating Expense (+$)
Research Development23,077,200
Selling General Administrative82,960,300
Selling And Marketing Expenses0
Operating Expense233,732,500106,037,500
 
Net Interest Income (+$)
Interest Income2,981,000
Interest Expense-1,720,000
Other Finance Cost-2,981,000
Net Interest Income-1,720,000
 
Pretax Income (+$)
Operating Income93,047,500
Net Interest Income-1,720,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)94,084,30092,489,700
EBIT - interestExpense = 95,798,810
93,211,700
86,455,800
Interest Expense1,720,000
Earnings Before Interest and Taxes (EBIT)97,518,81095,804,300
Earnings Before Interest and Taxes (EBITDA)122,813,110
 
After tax Income (+$)
Income Before Tax94,084,300
Tax Provision-8,475,900
Net Income From Continuing Ops85,129,40085,608,400
Net Income84,735,800
Net Income Applicable To Common Shares84,735,800
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses340,354,100
Total Other Income/Expenses Net557,8001,720,000
 

Technical Analysis of Sun Pharmaceutical Industries Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sun Pharmaceutical Industries Limited. The general trend of Sun Pharmaceutical Industries Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sun Pharmaceutical Industries Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sun Pharmaceutical Industries Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1,535 < 1,639.

The bearish price targets are: 1,328 > 1,238 > 1,227.

Tweet this
Sun Pharmaceutical Industries Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sun Pharmaceutical Industries Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sun Pharmaceutical Industries Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Moving Average Convergence/Divergence (MACD) ChartSun Pharmaceutical Industries Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sun Pharmaceutical Industries Limited. The current adx is .

Sun Pharmaceutical Industries Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Relative Strength Index (RSI) ChartSun Pharmaceutical Industries Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Stochastic Oscillator ChartSun Pharmaceutical Industries Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Commodity Channel Index (CCI) ChartSun Pharmaceutical Industries Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Chande Momentum Oscillator (CMO) ChartSun Pharmaceutical Industries Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Williams %R ChartSun Pharmaceutical Industries Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Average True Range (ATR) ChartSun Pharmaceutical Industries Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily On-Balance Volume (OBV) ChartSun Pharmaceutical Industries Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sun Pharmaceutical Industries Limited.

Sun Pharmaceutical Industries Limited Daily Money Flow Index (MFI) ChartSun Pharmaceutical Industries Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sun Pharmaceutical Industries Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Sun Pharmaceutical Industries Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sun Pharmaceutical Industries Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,545.550
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sun Pharmaceutical Industries Limited with someone you think should read this too:
  • Are you bullish or bearish on Sun Pharmaceutical Industries Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sun Pharmaceutical Industries Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sun Pharmaceutical Industries Limited

I send you an email if I find something interesting about Sun Pharmaceutical Industries Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Sun Pharmaceutical Industries Limited.

Receive notifications about Sun Pharmaceutical Industries Limited in your mailbox!